ABSTRACTS Archives - Page 49 of 107

P07 Unravelling oncogenic signalling induced by JAK3 mutations in a model of T-cell acute lymphoblastic leukemia (T-ALL)

BJH - volume 8, issue Abstract Book BHS, february 2017

I. Govaerts , S. Degryse , C. De Bock , K. Jacobs PhD, S. Binos , M. Dun , J. Cools

P08 Immunotherapy in Multiple Myeloma using alfa-galactosylceramide loaded sEVs from dendritic cells to stimulate NKT activity

BJH - volume 8, issue Abstract Book BHS, february 2017

S. Faict , M. Favreau , E.D.B. E. , K. De Veirman , dr. K. Maes , K. Vanderkerken PhD, R. Schots MD, PhD, E. Menu

P09 DARPin® molecule MP0250, a new antiangiogenic drug in multiple myeloma: An in vitro and in vivo study

BJH - volume 8, issue Abstract Book BHS, february 2017

K. De Veirman , L. Rao , M.A. Frassanito , V. Desantis , D. Giannico , L. di Marzo , U. Fiedler , A. Harstrick , D. Ribatti , K. Vanderkerken PhD, A. Vacca

P10 The genetic landscape of the murine 5T models for multiple myeloma

BJH - volume 8, issue Abstract Book BHS, february 2017

dr. K. Maes , B. Boeckx , L. De Beck , E. Menu , K. De Veirman , K. Vanderkerken PhD, D. Lambrechts , E. De Bruyne

P11 Low-pass sequencing of plasma cell DNA and of circulating cell-free DNA for the detection of copy number aberrations and early response monitoring in multiple myeloma

BJH - volume 8, issue Abstract Book BHS, february 2017

B. Dewaele PhD, S. Smits , L. Dehaspe , N. Brison , J. Ding , J. Van Houdt , H. Lemmens , L. Michaux MD, PhD, J. Vermeesch , P. Vandenberghe MD, PhD

P12 The glycan-binding galectin-1 is involved in osteoclast biology

BJH - volume 8, issue Abstract Book BHS, february 2017

J. Muller MSc, M. Binsfeld , S. Dubois , G. Carmeliet , Y. Beguin MD, PhD, R. Heusschen PhD, J. Caers MD, PhD

P13 Monoclonal Gammopathy of Undetermined Significance (MGUS) after kidney transplantation: prevalence and clinical significance

BJH - volume 8, issue Abstract Book BHS, february 2017

B. Heymans , D. Dierickx MD, PhD, B. Sprangers MD, PhD